NSRX
Nasus Pharma
$3.35
−$0.20 (−5.63%)Sep 10, 2026
Key metrics
The numbers that frame NSRX today
- Market cap
- $39.23M
- P/E (TTM)
- -3.7
- EV / FCF
- -3.0
- ROIC
- -1,685%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $1.98
- 52wk High
- $9.50
Growth
Revenue and earnings trend for NSRX
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about NSRX
Is Nasus Pharma a good buy?
No. Nasus Pharma has poor quality and poor momentum. Both signals point to a weaker setup. We think Nasus Pharma is selling at a very high price.
What is the market capitalization of NSRX?
Nasus Pharma's market capitalization is $39.23M.
What is the P/E ratio for NSRX stock?
Nasus Pharma's current P/E ratio is -3.7.
What is the 52-week high for NSRX stock?
The 52-week high for Nasus Pharma is $9.50. The current close of $3.35 is 64.7% below that high.
What is the 52-week low for NSRX stock?
The 52-week low for Nasus Pharma is $1.98. The current close of $3.35 is 69% above that low.
Does NSRX stock pay dividends?
Nasus Pharma does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for NSRX?
Nasus Pharma's Debt / Equity ratio is 0.01.